ENVERIC BIOSCIENCES, INC. Other Comprehensive Income (Loss), before Tax
ENVERIC BIOSCIENCES, INC. (ENVB) reported Other Comprehensive Income (Loss), before Tax of -$6.53 million for the 12-month period ending 2016-12-31, per its 10-K/A filed 2017-04-04.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeTax · last filed 2017-04-04
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), before tax for the quarter ending 2016-12-31 was -$2.44M.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), before tax for the quarter ending 2016-09-30 was -$1.78M.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), before tax for the quarter ending 2016-06-30 was -$1.21M, a 882.75% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), before tax for the quarter ending 2016-03-31 was -$1.10M, a 201.73% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), before tax for fiscal 2016 was -$6.53M.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), before tax for fiscal 2015 was -$942.53K.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), before tax for fiscal 2015 was $641.36K, a 2.11% increase from fiscal 2014.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), before tax for fiscal 2014 was $628.12K.
| Period end | Other Comprehensive Income (Loss), before Tax 3 month | Other Comprehensive Income (Loss), before Tax 6 month | Other Comprehensive Income (Loss), before Tax 9 month | Other Comprehensive Income (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$2.44M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-04-04 | -$4.22M derived: sum of 2 quarters · filed 2017-04-04 | -$5.43M derived: sum of 3 quarters · filed 2017-04-04 | -$6.53M 10-K/A · filed 2017-04-04 |
| 2016-09-30 | -$1.78M 10-Q · filed 2016-11-14 | -$2.99M derived: sum of 2 quarters · filed 2016-11-14 | -$4.08M 10-Q · filed 2016-11-14 | -$5.88M derived: sum of 4 quarters · filed 2017-04-04 |
| 2016-06-30 | -$1.21M 10-Q · filed 2016-08-12 | -$2.30M 10-Q · filed 2016-08-12 | -$4.10M derived: sum of 3 quarters · filed 2017-04-04 | -$4.48M derived: sum of 4 quarters · filed 2017-04-04 |
| 2016-03-31 | -$1.10M 10-Q · filed 2016-05-16 | -$2.89M derived: sum of 2 quarters · filed 2017-04-04 | -$3.27M derived: sum of 3 quarters · filed 2017-04-04 | -$3.11M derived: sum of 4 quarters · filed 2017-04-04 |
| 2015-12-31 | -$1.80M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-04-04 | -$2.17M derived: sum of 2 quarters · filed 2017-04-04 | -$2.02M 10-KT · filed 2016-03-15 | -$942.53K 10-K/A · filed 2017-04-04 |
| 2015-09-30 | -$377.82K 10-Q · filed 2016-11-14 | -$223.37K derived: sum of 2 quarters · filed 2016-11-14 | $853.32K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $154.46K 10-Q · filed 2016-08-12 | $1.23M 10-Q · filed 2016-08-12 | ||
| 2015-03-31 | $1.08M 10-Q · filed 2016-05-16 | $641.36K 10-KT · filed 2016-03-15 | ||
| 2014-06-30 | $566.60K 10-Q · filed 2015-08-18 | |||
| 2014-03-31 | $628.12K 10-KT · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |